Autocrine expression of activated transforming growth factor-β1 induces apoptosis in normal rat liver

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 280, Issue 1 43-1, 2001, Pages

  Schrum, Laura W ^a   Bird, Mark A ^a   Salcher, Olga ^b   Burchardt, Elmar Reinhold ^b   Grisham, Joe W ^a   Brenner, David A ^a   Rippe, Richard A ^a   Behrns, Kevin E ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b BAYER PHARMA AG   (Germany)

Author keywords

Adenovirus; Caspase activity; Growth factors; Hepatic regeneration; Partial hepatectomy

Indexed keywords

CASPASE INHIBITOR; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; APOPTOSIS; ARTICLE; AUTOCRINE EFFECT; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; GENE ACTIVATION; GENE EXPRESSION; GROWTH REGULATION; LIVER CELL; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TRANSGENE;

EID: 0035008601     PISSN: 01931857     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpgi.2001.280.1.g139     Document Type: Article

References (53)

1. Alexandrow M and Moses H. Transforming growth factor B and cell cycle regulation. Cancer Res 55: 1452-1457, 1995.
2. Atfi A, Buisine M, Mazars A, and Gespach C. Induction of apoptosis by DPC4, a transcriptional factor regulated by transforming growth factor-B through stress-activated protein kinase/ c-Jun N-terminal kinase (SAPK/JNK) signaling pathway. J Biol Chem 272: 24731-24734, 1997.
3. Barcellos-Hoff M and Dix T. Redox-mediated activation of latent transforming growth factor-beta 1. Mol Endocrinol 10: 1077-1083, 1996.
4. Benedetti A, DiSario A, Baroni G, and Jezequel A. Transforming growth factor B1 increases the number of apoptotic bodies and decreases intracellular pH in isolated periportal and perivenular rat hepatocytes. Hepatology 22: 1488-1498, 1995.
5. Bissell D, Wang S-S, Jarnagin W, and Roll F. Cell specific expression of tranforming growth factor beta in rat liver: evidence for autocrine regulation of hepatocyte proliferation. J Clin Invest 96: 447-455, 1995.
6. Bottinger E, Factor V, Tsang M-S, Weatherbee J, Kopp J, Qian S, Wakefield L, Roberts A, Thorgeirsson S, and Sporn M. The recombinant proregion of transforming growth factor B1 (Latency-associated peptide) inhibits active transforming growth factor B1 in trangenic mice. Proc Natl Acad Sci USA 93: 5877-5882, 1996.
7. Brenner D, Rippe R, Rhodes K, Trotter T, and Breindl M. Fibrogenesis and type I collagen gene regulation. J Lab Clin Med 124: 755-760, 1994.
8. Bursch W, Oberhammer F, Jirtle R, Askari M, Sedivy R, Grasl-Kraupp B, Purchio A, and Schulte-Hermann R. Transforming growth factor-B1 as a signal for induction of cell death by apoptosis. Br J Cancer 67: 531-536, 1993.
9. Carr B, Huang T, Itakura K, Noel M, and Marceau N. TGFB gene transcription in normal and neoplastic liver growth. J Cell Biochem 39: 477-487, 1989.
10. Chen R-H and Chang T-Y. Involvement of caspase family proteases in transforming growth factor-B induced apoptosis. Cell Growth Differ 8: 821-827, 1997.
11. Choi K, Lim I, Brady J, and Kim S-J. ICE-like protease (caspase) is involved in transforming growth factor B1-mediated apoptosis in FAO rat hepatoma cell line. Hepatology 27: 415-421, 1998.
12. Chuang L-Y, Hung W-C, Chang C-C, and Tsai J-H. Characterization of apoptosis induced by transforming growth factor B 1 in human hepatoma cells. Anticancer Res 14: 147-152, 1994.
13. Columbano A, Ledda-Columbano G, Coni P, Faa G, Liguori C, Cruz G, and Pani P. Occurrence of cell death (apoptosis) during involution of liver hyperplasia. Lab Invest 52: 670-675, 1985.
14. Dennis P and Rifkin D. Cellular activation of latent transforming growth factor B requires binding to the cation-independent mannose 6-phosphate/insulin like growth factor type II receptor. Proc Natl Acad Sci USA 88: 580-584, 1991.
15. Fan G, Xu R, Wessendorf M, Ma X, Kren B, and Steer C. Modulation of retinoblastoma and retinoblastoma-related proteins in regenerating rat liver and primary hepatocytes. Cell Growth Differ 6: 1463-1476, 1995.
16. Fausto N, Laird D, and Webber E. Role of growth factors and cytokines in hepatic regeneration. FASEB J 9: 1527-1536, 1995.
17. Gao C, Gressner G, Zoremba M, and Gressner A. Transforming growth factor B1 (TGF-B) expression in isolated and cultured rat hepatocytes. J Cell Physiol 167: 394-405, 1996.
18. Geng Y and Weinberg R. Transforming growth factor B effects on expression of G1 cyclins and cyclin-dependent kinases. Proc Natl Acad Sci USA 90: 10315-10319, 1993.
19. Gentry L and Nash B. The pro domain of pre-pro transforming growth factor B1 when independently expressed is a functional binding protein for the mature growth factor. Biochemistry 29: 6851-6857, 1990.
20. Gressner A, Lahme B, and Roth S. Attenuation of TGF-B-induced apoptosis in primary cultures of hepatocytes by calpain inhibitors. Biochem Biophys Res Commun 231: 457-462, 1997.
21. Gressner A, Polzar B, Lahme B, and Mannherz H-G. Induction of rat liver parenchymal cell apoptosis by hepatic myofiblasts via transforming growth factor B. Hepatology 23: 571-581, 1996.
22. Hatano E, Bradham CA, Stark A, Iimuro Y, Lemasters JJ, and Brenner DA. The mitochondrial permeability transition augments Fas-induced apoptosis in mouse hepatocytes. J Biol Chem 275: 11814-11823, 2000.
23. Heldin C-H, Miyazono K, and Dijke PT. TGF-B signalling from cell membrane to nucleus through SMAD proteins. Nature 390: 465-471, 1997.
24. Hellerbrand C, Stefanovic B, Giordano F, Burchardt E, and Brenner D. The role of TGFb1 in initiating hepatic stellate cell activation in vivo. J Hepatol 30: 77-87, 1999.
25. Higgins G and Anderson R. Experimental pathology of the liver: restoration of the liver of the white rat following partial surgical removal (Abstract). Arch Pathol 12: 186, 1931.
26. Inayat-Hussain S, Couet C, Cohen G, and Cain K. Processing/activation of CPP32-like proteases is involved in tranforming growth factorB1-induced apoptosis in rat hepatocytes. Hepatology 25: 1516-1526, 1997.
27. Jakowlew S, Mead J, Danielpour D, Wu J, Roberts A, and Fausto N. Transforming growth factor-B isoforms in rat liver regeneration: messenger RNA expression and activation of latent TGF-B. Cell Regul 2: 535-548, 1991.
28. Laiho M, DeCaprio J, Ludlow J, Livingston D, and Massague J. Growth inhibition by TGF-beta linked to suppression of retinoblastoma protein phosphorylation. Cell 62: 175-185, 1990.
29. Lyons R, Keski-Oja J, and Moses H. Proteolytic activation of latent transforming growth factor-B from fibroblast-conditioned medium. J Cell Biol 106: 1659-1665, 1988.
30. Maizel J, White D, and Scharff M. The polypeptides of adenovirus. II. Soluble proteins, top components and the structure of the virion. Virology 36: 126-136, 1968.
31. McGowan J, Strain A, and Bucher N. DNA synthesis in primary cultures of adult rat hepatocytes in a defined medium: effects of epidermal growth factor, insulin, glucagon, and cyclic-AMP. J Cell Physiol 180: 353-363, 1981.
32. Mead J and Fausto N. Transforming growth factor alpha may be a physiologic regulator of liver regeneration by means of an autocrine mechanism. Proc Natl Acad Sci USA 86: 1558-1562, 1989.
33. Munger J, Huang X, Kawakatsu H, Griffiths M, Dalton S, Wu J, Pittet J-F, Kaminski N, Garat C, Matthay M, Rifkin D, and Sheppard D. The integrin avB6 binds and activates latent TGFB1: a mechanism for regulating pulmonary inflammation and fibrosis. Cell 96: 319-328, 1999.
34. Nakamura T, Nishizawa T, Hagiya M, Seki T, Shimonishi M, Sugimura A, Tashiro K, and Shimizu S. Molecular cloning and expression of human hepatocyte growth factor. Nature 342: 440-443, 1989.
35. Nakamura T, Tomita Y, Hirai R, Yamaoka K, Kaji K, and Ichihara A. Inhibitory effect of transforming growth factor-B on DNA synthesis of adult rat hepatocytes in primary culture. Biochem Biophys Res Commun 133: 1042-1050, 1985.
36. Oberhammer F, Nagy P, Tiefenbacher R, Froschl G, Bouzahzah B, Thorgeirsson S, and Carr B. The antiandrogen cyproterone acetate induces synthesis of transforming growth factor B1 in the parenchymal cells of the liver accompanied by an enhanced sensitivity to undergo apoptosis and necrosis without inflammation. Hepatology 23: 329-337, 1996.
37. Oberhammer F, Pavelka M, Sharma S, Tiefenbacher R, Purchio A, Bursch W, and Schulte-Hermann R. Induction of apoptosis in cultured hepatocytes and in regressing liver by transforming growth factor B1. Proc Natl Acad Sci USA 89: 5408-5412, 1992.
38. Ohno K, Ammann P, Fasciati R, and Maier P. Transforming growth factor B1 preferentially induces apoptotic cell death in rat hepatocytes cultured under pericentral-equivalent conditions. Toxicol Appl Pharmacol 132: 227-236, 1995.
39. Rippe R, Almounajed G, and Brenner D. Sp1 binding activity increases in activated Ito cells. Hepatology 22: 241-251, 1995.
40. Russell W, Coffey R, Ouellette A, and Moses H. Type B transforming growth factor reversibly inhibits the early proliferative response to partial hepatectomy in the rat. Proc Natl Acad Sci USA 85: 5126-5130, 1988.
41. Sambrook J, Fritsch E, and Maniatis T. Molecular Cloning: A Laboratory Manual. Plainview, NY: Cold Spring Harbor Laboratory, 1989.
42. Sanderson N, Factor V, Nagy P, Kopp J, Kondaiah P, Wakefield L, Roberts A, Sporn M, and Thorgeirsson S. Hepatic expression of mature transforming growth factor B1 in transgenic mice results in multiple tissue lesions. Proc Natl Acad Sci USA 92: 2572-2576, 1995.
43. Schrum L, Black D, Rippe R, Brenner D, and Behrns K. c-Jun does not mediate hepatocyte apoptosis following NFkB inhibition and partial hepatectomy. J Surg Res 88: 142-149, 2000.
44. Schultz-Cherry S, Chen H, Mosher D, Krutzsch T, Roberts D, and Murphy-Ullrich J. Regulation of transforming growth factor-beta activation by discrete sequences of thrombospondin 1. J Biol Chem 270: 7304-7310, 1995.
45. Schultz-Cherry S and Murphy-Ullrich J. Thrombospondin causes activation of latent transforming growth factor-beta secreted by endothelial cells by a novel mechanism. J Cell Biol 122: 923-932, 1993.
46. Sime P, Xing Z, Graham F, Csaky K, and Gauldie J. Adenovector-mediated gene transfer of active transforming growth factor B1 induces prolonged severe fibrosis in rat lung. J Clin Invest 100: 768-776, 1997.
47. Slingerland J, Hengst L, Pan C-H, Alexander D, Stampfer M, and Reed S. A novel inhibitor of cyclin-cdk activity detected in transforming growth factor B-arrested epithelial cells. Mol Cell Biol 14: 3683-3694, 1994.
48. Strain A, Frazer A, Hill D, and Milner R. Transforming growth factor B inhibits DNA synthesis in hepatocytes isolated from normal and regenerating rat livers. Biochem Biophys Res Commun 145: 436-442, 1987.
49. Villarreal FJ, Lee AA, Dillman WH, and Giordano FJ. Adenovirus-mediated overexpression of human transforming growth factor-B1 in rat cardiac fibroblasts, myocytes and smooth muscle cells. J Mol Cell Cardiol 28: 735-742, 1996.
50. Whitson R and Itakura K. TGF-beta inhibits DNA synthesis and phosphorylation of the retinoblastoma gene product i a rat liver epithelial cell line. J Cell Biochem 48: 305-315, 1992.
51. Wrana J, Attisano L, Wieser R, Ventura F, and Massague J. Mechanism of activation of TGF-B receptor. Nature 370: 341-347, 1994.
52. Xing Z, Ohkawara Y, Jordana M, Graham F, and Gauldie J. Transfer of granulocyte-macrophage colon-stimulating factor gene to rat lung induces eosinophilia. J Clin Invest 97: 1102-1110, 1996.
53. Zarngar R and Michalopoulos G. Purification and biologic characterization of human hepatopoieten A, a polypeptide growth factor for hepatocytes. Cancer Res 49: 3314-3320, 1989.